The invention provides a method for preventing or treating diseases related to CSNK2B
gene deletion. The disclosure also provides a CSNK2B
protein or a variant thereof, a
nucleic acid molecule encoding a CSNK2B
protein or a variant thereof, an
expression cassette comprising a
nucleic acid molecule encoding a CSNK2B
protein or a variant thereof, a vector comprising a
nucleic acid molecule encoding a CSNK2B protein or a variant thereof, a
virus, such as an AAV particle, expressing a CSNK2B protein or a variant thereof, and a method for preparing the CSNK2B protein or a variant thereof. According to the present invention, the use of the cells expressing the CSNK2B protein in the preparation of drugs for treating or preventing CSNK2B
gene deletion-related diseases in subjects is provided, and the CSNK2B
gene deletion-related diseases are selected from the group consisting of
Rett syndrome,
autism spectrum disorder (ASD), Porier-Bienvenu neurodevelopment syndrome (POBINDS),
epilepsy or broad-spectrum development retardation, or the use of the cells expressing the CSNK2B protein in the preparation of the drugs for treating or preventing the CSNK2B
gene deletion-related diseases in the subjects,